Propranolol + Candesartan (Answer: c)
The combination of propranolol and candesartan provides dual benefit for both hypertension control and migraine prophylaxis, making option C the correct answer. Both medications have established evidence as first-line agents for migraine prevention while simultaneously treating hypertension.
Evidence-Based Rationale
Propranolol for Migraine Prevention
Propranolol is consistently recommended as a first-line agent for migraine prophylaxis across multiple guidelines 1, 2, 1, 2. The evidence for propranolol's efficacy is robust, with recommended dosing of 80-240 mg daily 1. The 2024 VA/DoD guidelines provide a weak recommendation for propranolol in migraine prevention 3, while older but well-established guidelines from 2002-2003 demonstrate good evidence for its efficacy 2.
Candesartan for Migraine Prevention
Candesartan, an angiotensin II receptor blocker (ARB), has strong evidence supporting its use in episodic migraine prevention. The most recent 2024 VA/DoD guidelines provide a strong recommendation for candesartan in preventing episodic migraine 3. A 2023 meta-analysis demonstrated that ARBs, including candesartan, significantly reduce monthly headache days by -0.9 days (95% CI: -1.6, -0.1) 4. Research specifically on candesartan 16 mg showed superiority over placebo with greater than 50% reduction in migraine attack frequency 5.
Why Other Options Are Incorrect
Amlodipine (Option A): While calcium channel blockers have some evidence for migraine prevention, amlodipine specifically is not recommended in major guidelines for this indication. The evidence focuses primarily on other calcium channel blockers like verapamil and nicardipine 4.
Minoxidil (Option B): This vasodilator has no established role in migraine prevention. It is used for refractory hypertension and hair loss, but lacks any evidence for migraine prophylaxis.
Furosemide (Option D): Loop diuretics have no evidence for migraine prevention. In fact, diuretics are not mentioned in any migraine prevention guidelines, and their use could potentially trigger headaches through dehydration.
Clinical Implementation
Dosing Strategy
- Propranolol: Start at 80 mg daily, titrate up to 240 mg daily as tolerated 1
- Candesartan: Use 16 mg daily based on RCT evidence 5
Important Considerations
Propranolol contraindications and cautions:
- Avoid in patients with asthma, severe COPD, or heart block
- Use cautiously in diabetes (may mask hypoglycemia)
- Common side effects: fatigue, depression, dizziness, insomnia 2
- Consider avoiding long-term use in absence of ischemic heart disease due to potential unfavorable cardiovascular effects 6
Candesartan advantages:
- Well-tolerated with minimal side effects
- Particularly useful in patients with comorbid hypertension 5
- May be superior to propranolol in some measures based on recent comparative data 7
Timeline for Efficacy
Both medications require adequate trial periods of 2-3 months before assessing full therapeutic benefit 2. Start with low doses and titrate slowly to minimize adverse effects while achieving clinical benefits.
Monitoring Parameters
- Blood pressure at each visit (every 3 months minimum)
- Migraine frequency, severity, and duration via headache diary
- Functional disability and quality of life assessment
- Adverse effects, particularly fatigue and dizziness with propranolol
This combination is particularly advantageous in patients with both hypertension and frequent migraines (≥2 attacks per month producing disability for ≥3 days) 1, 3, allowing treatment of both conditions with evidence-based medications rather than using agents that only address one condition.